| Financial Year |
March 31 2023 |
| Monetary Funds |
37,470,594.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
31,791,984.46 |
| Accounts Receivable |
142,503,055.56 |
| Advances to Suppliers |
2,020,801.53 |
| Other Receivables |
5,020,004.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
230,419,410.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
157,030.35 |
| Total Current Assets |
451,650,578.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
298,649,970.91 |
| Under-construction Projects |
58,757,814.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
192,434,816.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,395,473.05 |
| Deferred Income Tax Assets |
5,373,311.06 |
| Other Non-Current Assets |
7,275,449.44 |
| Sub-Total of Non-Current Assets |
569,091,266.42 |
| Total Assets |
1,020,741,845.27 |
| Short-Term Loans |
99,168,000.00 |
| Trading Financial liabilities |
328,602.95 |
| Notes Payable |
-- |
| Accounts Payable |
97,271,590.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,326,492.36 |
| Taxes Payable |
8,072,473.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,248,642.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,914,677.29 |
| Other Current Liabilities |
31,869,874.34 |
| Sub-Total of Current Liabilities |
343,610,645.42 |
| Long-term Loans |
93,842,796.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
186,642,236.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,142,339.11 |
| Deferred Income Tax Liabilities |
975,062.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
294,009,693.21 |
| Total Liabilities |
637,620,338.63 |
| Paid-In Capital(Or Share Stock) |
138,000,000.00 |
| Capital Surplus |
221,043,538.26 |
| Surplus Reserve |
21,766,113.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,637,068.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
383,121,506.64 |
| Owner's Equity（Stockholder's Equity） |
383,121,506.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,020,741,845.27 |
